EFFICACY OF TRIFLUOPERAZINE IN CHRONIC MENTAL ILLNESS
Abstract
Trifluoperazine is considered to be of limited usefulness and considerable toxicity in an elderly female population.
The 8 patients with increased muscular rigidity having 4 of their number improved by Stelazine should be contrasted with the absence of psychiatric improvement among the 8 women with muscular weakness. Investigation of this phenomenon may reveal clues to the operation of trifluoperazine.
On the positive side, no agranulocytic, hepatotoxic, or biliary static effects were noted. A therapeutic agent which can improve the ward management of one-fifth of the severely and chronically ill patients should be considered as part of the psychotherapeutic armamentarium.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).